Berger Montague Advises Investors on Zynex Securities Fraud Class Action Lawsuit Deadline
Zynex, Inc. Faces Class Action Lawsuit Amid Investor Concerns
In a significant turn of events for investors in Zynex, Inc. (NASDAQ: ZYXI), Berger Montague PC has formally announced the initiation of a securities class action lawsuit against the medical device company. The lawsuit pertains to Zynex’s activities during the class period spanning from March 13, 2023, to March 11, 2025, a timeframe that saw substantial stock price fluctuations and allegations of misleading business practices.
Background on Zynex, Inc.
Zynex, Inc., headquartered in Englewood, Colorado, specializes in manufacturing electrotherapy devices aimed primarily at pain management and rehabilitation. Although the company had previously enjoyed a favorable reputation, recent reports have raised serious concerns about its operational integrity and marketing tactics.
Allegations of Unlawful Practices
The lawsuit underscores troubling allegations that Zynex has engaged in an
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.